Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowAugust 04, 2026 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Freenome (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests to detect cancer when it is most treatable, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Aaron Elliott, Ph.D., Chief Executive Officer, rings the Opening Bell.
